update
Oystar sells processing tech units to Bosch
Oystar has sold its processing tech units, Huttlin and Manesty, to Bosch in a deal that continues its effort to refocus on primary and secondary packaging.
Archives for April 26, 2011
Appointments at Cetero, Harlan, Numerate and Idea Pharma – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Cetero, Harlan, Numerate and Idea Pharma.
Strong clinical development revs offset PPD lab cancellations
Laboratory service cancellations impacted PPD in the first quarter but strong clinical development performance kept results in line with expectations.
Space, the final frontier for drug stability says NASA study
The finding that space flight is detrimental to drug stability may have implications for drug packaging, dispensing technologies and mail order delivery according to a NASA study.
Developers pursuing new strategies to improve trial efficiency: Tufts CSDD
Drug developers are pursuing new strategies to help improve the operational efficiency of their clinical trials, according to a panel of industry leaders recently convened by the Tufts Centre for the Study of Drug Development (CSDD) in Boston, US.
USP and ChP forge stronger links with new appointments
The United States Pharmacopeial Convention (USP) and the Chinese Pharmacopoeia Commission (ChP) have made mutual executive appointments in an effort to further align drug quality standards.
Teva resumes production at Irvine, CA facility
Teva has resumed production at its Irvine, California plant a year after quality control issues put production on hold.
Eli Lilly and Medtronic to collaborate on developing new Parkinson’s treatment
Pharma giant Eli Lilly and medical device maker Medtronic are to collaborate on the research and development of an implantable drug delivery system for the treatment of Parkinson’s disease.